期刊文献+

平脂养肝汤治疗非酒精性脂肪肝临床研究 被引量:3

下载PDF
导出
摘要 目的探讨平脂养肝汤治疗非酒精性脂肪肝的临床疗效。方法将80例非酒精性脂肪肝患者随机分为治疗组和对照组,治疗组给予平脂养肝汤,每日一剂,水煎两次,各150ml,混合后分两次口服;对照组给予脂必妥,每次3粒,每天3次,联合口服东宝肝泰片,4粒/次,每日3次。两组均以3周为一个疗程,连续治疗3个疗程。结果平脂养肝汤在改善症状、血脂、肝功能、肝脏B超指标方面与对照组比较有显著差异。结论平脂养肝汤具有具有显著降脂、降酶作用,治疗非酒精性脂肪肝疗效确切,安全可靠。
作者 贾满仓
出处 《光明中医》 2012年第4期720-721,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
  • 相关文献

参考文献9

  • 1范建高;曾民德.脂肪肝[M]上海:复旦大学出版社,2000101.
  • 2曾民德.降脂药物在脂肪肝治疗中的应用[J]中华肝脏病杂志,2000(02):106.
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 4范建高;曾民德.脂肪肝[M]上海:上海医科大学出版社,2001107-112.
  • 5中华人民共和国卫生部.中药新临床研究指导原则(试行)[M]北京:中国医药科技出版社,2002135-148.
  • 6张灵芝,赵元昌,韩德五,陈贤明,许瑞龄,尹镭,马学惠.丹参在抗肝细胞坏死中的钙拮抗作用[J].中国病理生理杂志,1993,9(2):191-195. 被引量:40
  • 7吴春福,刘雯,解庆峰,吕彤岩,于庆海.小柴胡汤对大鼠肝线粒体的单胺氧化酶的抑制作用[J].沈阳药学院学报,1991,8(3):207-210. 被引量:7
  • 8沈映君.中药药理学[M]上海:上海科技学技术出版社,199934-3569-7290-91115-116128-129174-175.
  • 9肖培根.新编中药志[M]北京:化学工业出版社,200274769222.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1551

同被引文献75

  • 1刘文全,邵凤珍.肝脂乐颗粒治疗非酒精性脂肪肝90例临床观察[J].中医药临床杂志,2005,17(5):482-483. 被引量:6
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 3张加军,张广业.散瘀化浊汤治疗非酒精性脂肪肝临床研究[J].中华中医药学刊,2007,25(1):176-178. 被引量:11
  • 4中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].药品评价,2007,4(2):77-79. 被引量:43
  • 5中华人民共和国卫生部.中药新临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002:135-148.
  • 6周显华,张传涛,郑政隆,范昕建,张莉敏,杨鸿,李白雪,张晓婷,周威龙.加味楂曲饮治疗非酒精性脂肪肝的临床疗效及机制研究.加味楂曲饮治疗非酒精性脂肪肝的临床疗效及机制研究 2013;19:285-288.
  • 7张玉禄,周英武,张进虎,刘媛媛.健脾化浊法对非酒精性脂肪肝患者瘦素的影响及疗效分析.中医中药,2012;2:97-99.
  • 8Aygun C, Kocaman O, Sahin T, et al. Evaluation of metabolic syndrome frequency and caroti- dartery intima-media thickness as risk factors for atherosclerosis intima-media thickness as risk factors for atheroscle- rosis in patients with nonalcoholic fatty liver disease [J]. Dig Dis Sci, 2008, 53(5):1352-1357.
  • 9Alkhouri N, Tamimi TA, Yerian L, et al. The inflamed liver and atherosclerosis: a link between histologie severity of nonalcoholic fatty liver disease and increased cardiovascular risk [J].Dig Dis Sei, 2010, 55 (9):2644-2650.
  • 10Schnedl WJ, Wallner SJ, Piswanger C, et al. Glycated hemoglobin and disease in diabetes mellitus [J].Wien Med Wochenschr, 2005, 155 (17- 18):411-415.

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部